Showing 251-260 of 273 results for "".
- New ASPS Stats Show 50,000 More Cosmetic Procedures Performed in Adults Age 55+ in 2018https://modernaesthetics.com/news/new-asps-stats-show-50000-more-cosmetic-procedures-performed-in-adults-age-55-in-2018/2471895/More Americans age 55 and older are seeking cosmetic procedures, according to the latest statistics from the
- Allergan Upgrades Brilliant Distinctions® Patient Loyalty Programhttps://modernaesthetics.com/news/allergan-upgrades-brilliant-distinctions-patient-loyalty-program/2472200/Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and dr
- Lights, Camera, Botox!https://modernaesthetics.com/news/lights-camera-botox/2473185/Allergan Aesthetics is hosting an open casting call seeking people who would like to share their BOTOX Cosmetic Story. Building on the success of the original
- Call for Entries: Merz Aesthetics Announces First-Ever Innovation Forumhttps://modernaesthetics.com/news/call-for-entries-merz-aesthetics-announces-first-ever-innovation-forum/2473021/Merz Aesthetics is launching its first-ever Innovation Forum with a call for abstract submissions seeking the most creative and inventive medical aesthetics abstracts from the next generation of researchers and healthcare professionals. The author of the winning abstrac
- Galderma, Colorescience to Collaborate on Innovative Skincarehttps://modernaesthetics.com/news/galderma-colorescience-to-collaborate-on-innovative-skincare/2472266/Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable aesthetic treatments, the companies have announced. Galderma and
- Steady Increase in Facial Asymmetry with Aginghttps://modernaesthetics.com/news/steady-increase-in-facial-asymmetry-with-aging/2472000/Facial asymmetry increases steadily with age – a finding with important implications for facial rejuvenation and reconstructive procedures, reports a study in the November issue of Plastic and Reconstructive Surgery. Three-dimensional digital imaging techniques show a subtle but sig
- AAD Selects ContextMedia:Health as Patient Education Affinity Partnerhttps://modernaesthetics.com/news/aad-selects-contextmediahealth-as-patient-education-affinity-partner/2472318/ContextMedia:Health is now an Affinity Partner with the American Academy of Dermatology (AAD). The partnership offers ContextMedia:Health's suite of digital technology to the AAD's U.S. members at no cost. The agreement also bring
- SkinCeuticals Introduces A.G.E. Interrupter Ultra Serum to Address Sagging Skinhttps://modernaesthetics.com/news/skinceuticals-introduces-age-interrupter-ultra-serum-to-address-sagging-skin/2476036/SkinCeuticals announced the launch of its A.G.E. Interrupter Ultra Serum, a new addition to its A.G.E. line designed to target skin laxity. Sagging skin, often heightened by factors such as rapid weight loss, has become a growing concern among patients seeking dermatologic care. This serum offers
- Tattoo Removal Trends Revealed in Global Analysis of Over 200,000 Individualshttps://modernaesthetics.com/news/tattoo-removal-trends-revealed-in-global-analysis-of-over-200000-individuals/2475357/Key Takeaways Individuals aged 18–39 make up two-thirds of those seeking tattoo removal, with visible areas such as forearms and hands being the most treated. Black ink remains the most commonly removed tattoo pigment. Fitzpatrick Skin Types III and
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum toxin